IRIS Accounts Production v24.3.2.46 04733100 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh047331002023-04-30047331002024-04-30047331002023-05-012024-04-30047331002022-04-30047331002022-05-012023-04-30047331002023-04-3004733100ns15:EnglandWales2023-05-012024-04-3004733100ns14:PoundSterling2023-05-012024-04-3004733100ns10:Director12023-05-012024-04-3004733100ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3004733100ns10:SmallEntities2023-05-012024-04-3004733100ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3004733100ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3004733100ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3004733100ns10:FullAccounts2023-05-012024-04-300473310012023-05-012024-04-3004733100ns10:Director22023-05-012024-04-3004733100ns10:Director32023-05-012024-04-3004733100ns10:CompanySecretary12023-05-012024-04-3004733100ns10:RegisteredOffice2023-05-012024-04-3004733100ns5:CurrentFinancialInstruments2024-04-3004733100ns5:CurrentFinancialInstruments2023-04-3004733100ns5:ShareCapital2024-04-3004733100ns5:ShareCapital2023-04-3004733100ns5:RetainedEarningsAccumulatedLosses2024-04-3004733100ns5:RetainedEarningsAccumulatedLosses2023-04-3004733100ns5:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3004733100ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-05-012024-04-3004733100ns5:PlantMachinery2023-05-012024-04-3004733100ns5:IntangibleAssetsOtherThanGoodwill2023-04-3004733100ns5:IntangibleAssetsOtherThanGoodwill2024-04-3004733100ns5:IntangibleAssetsOtherThanGoodwill2023-04-3004733100ns5:PlantMachinery2023-04-3004733100ns5:PlantMachinery2024-04-3004733100ns5:PlantMachinery2023-04-3004733100ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3004733100ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 04733100 (England and Wales)








UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024

FOR

SCIENTIFIC AND MEDICAL SOLUTIONS LIMITED

SCIENTIFIC AND MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 04733100)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SCIENTIFIC AND MEDICAL SOLUTIONS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTORS: Dr I C Kilpatrick
Ms R J Redfern
B T Kilpatrick





SECRETARY: Dr I C Kilpatrick





REGISTERED OFFICE: Brook Holm, Criftin Enterprise Centre
Oxton Road
Epperstone
Nottingham
NG14 6AT





REGISTERED NUMBER: 04733100 (England and Wales)





ACCOUNTANTS: Jane Cooksey Limited
15/16 Boarshurst Bus. Park,
Boarshurst Lane, Greenfield
Oldham
Lancashire
OL3 7ER

SCIENTIFIC AND MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 04733100)

BALANCE SHEET
30 APRIL 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1 1
Tangible assets 5 1,513 1,452
1,514 1,453

CURRENT ASSETS
Stocks 225 250
Debtors 6 8,080 3,788
Cash at bank 3,976 4,689
12,281 8,727
CREDITORS
Amounts falling due within one year 7 5,911 4,595
NET CURRENT ASSETS 6,370 4,132
TOTAL ASSETS LESS CURRENT
LIABILITIES

7,884

5,585

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 7,882 5,583
SHAREHOLDERS' FUNDS 7,884 5,585

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 February 2025 and were signed on its behalf by:



Dr I C Kilpatrick - Director


SCIENTIFIC AND MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 04733100)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

Scientific and Medical Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off over five years.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

SCIENTIFIC AND MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 04733100)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 May 2023
and 30 April 2024 5,013
AMORTISATION
At 1 May 2023
and 30 April 2024 5,012
NET BOOK VALUE
At 30 April 2024 1
At 30 April 2023 1

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023 13,957
Additions 566
At 30 April 2024 14,523
DEPRECIATION
At 1 May 2023 12,505
Charge for year 505
At 30 April 2024 13,010
NET BOOK VALUE
At 30 April 2024 1,513
At 30 April 2023 1,452

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 8,080 3,788

SCIENTIFIC AND MEDICAL SOLUTIONS LIMITED (REGISTERED NUMBER: 04733100)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 5,194 3,783
Other creditors 717 812
5,911 4,595